Molecular mechanisms mediating mammalian mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK cell survival signals

Cell Growth and Differentiation

Volumn 12, Issue 8, 2001, Pages 397-408

  Ballif, B A ^a   Blenis, J ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; ENZYME INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PROTEIN BCL 2;

CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; ENZYME SPECIFICITY; ENZYME SUBSTRATE; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; APOPTOSIS; CELL COMMUNICATION; CELL SURVIVAL; HUMANS; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES;

EID: 0034881019     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (170)

1. The CD95 (APO-1/Fas), and the TRAIL (APO-2L) apoptosis systems
2. CD95's deadly mission in the immune system
3. Fas ligand-induced apoptosis
4. Caspases. Key players in programmed cell death
5. Mammalian caspases: Structure, activation, substrates, and functions during apoptosis
6. The Bcl-2 protein family
7. Bcl-2 family: Life-or-death switch
8. The role of the Bcl-2 family in the regulation of outer mitochondrial membrane permeability
9. Outer mitochondrial membrane permeability can regulate coupled respiration and cell survival
10. BCL-2 family members and the mitochondria in apoptosis
11. The biochemistry of apoptosis
12. Role of mitochondria in apoptosis
13. Mitochondria: Execution central
14. Mitochondria as the central control point of apoptosis
15. Mitochondrial control of cell death
16. The mitochondrion in cell death control: Certainties and incognita
17. Mitogen-activated protein kinase (MAPK/ERK) overrides the apoptotic signaling from Fas, TNF, and TRAIL receptors
18. Protein kinase C θ and epsilon promote T-cell survival by a RSK-dependent phosphorylation and inactivation of BAD
19. Epidermal growth factor protects epithelial cells against Fas-induced apoptosis: Requirement for Akt activation
20. The opposing roles of the Akt and c-Myc signalling pathways in survival from CD95-mediated apoptosis
21. Protection of CD95-mediated apoptosis by activation of phosphatidylinositide 3-kinase and protein kinase B
22. The Drosophila gene hid is a direct molecular target of Ras-dependent survival signaling
23. Ras promotes cell survival in Drosophila by downregulating hid expression
24. Meaningful relationships: The regulation of the Ras/Raf/ MEK/ERK pathway by protein interactions
25. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo
26. A synthetic inhibitor of the mitogen-activated protein kinase cascade
27. Identification of a novel inhibitor of mitogen-activated protein kinase kinase
28. Activation of the protein kinase ERK5/BMK1 by receptor tyrosine kinases. Identification and characterization of a signaling pathway to the nucleus
29. Protein kinases: Six degrees of separation?
30. Cellular survival: A play in three Akts
31. The regulation and activities of the multi-functional serine/threonine kinase Akt/PKB
32. Identification of CISK, a new member of the SGK kinase family that promotes IL-3-dependent survival
33. Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a)
34. Function for NF-κB in neuronal survival: Regulation by atypical protein kinase C
35. The PI3K-PDK1 connection: More than just a road to PKB
36. Intracellular signalling: PDK1-a kinase at the hub of things
37. Ribosomal S6 kinase 1 (RSK1) activation requires signals dependent on and independent of the MAP kinase ERK
38. Disruption of 3-phosphoinositide-dependent kinase 1 (PDK1) signaling by the anti-tumorigenic and anti-proliferative agent N-α-tosyl-L-phenylalanyl chloromethyl ketone
39. Negative regulation of the serine/threonine kinase B-Raf by Akt
40. Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt
41. Phosphorylation and regulation of Raf by Akt (protein kinase B)
42. Phosphatidylinositol 3-kinase is required for integrin-stimulated AKT and Raf-1/mitogen-activated protein kinase pathway activation
43. Role of phosphoinositide 3-kinase and endocytosis in nerve growth factor-induced extracellular signal-regulated kinase activation via Ras and Rap1
44. Phosphatidylinositol 3-kinase requirement in activation of the ras/C-raf-1/MEK/ERK and p70(s6k) signaling cascade by the insulinomimetic agent vanadyl sulfate
45. Role of phosphoinositide 3-kinase in activation of fas and mitogen-activated protein kinase by epidermal growth factor
46. Conditional inhibition of the mitogen-activated protein kinase cascade by wortmannin. Dependence on signal strength
47. Evidence from MEK-independent pathways regulating the prolonged activation of the ERK-MAP kinases
48. Ras signalling and apoptosis
49. Raf/MAPK and rapamycin-sensitive pathways mediate the anti-apoptotic function of p21Ras in IL-3-dependent hematopoietic cells
50. Ras regulates sympathetic neuron survival by suppressing the p53-mediated cell death pathway
51. Rsk1 mediates a MEK-MAP kinase cell survival signal
52. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms
53. p90(RSK) blocks bad-mediated cell death via a protein kinase C-dependent pathway
54. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
55. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt
56. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L)
57. Regulation of BAD phosphorylation at serine 112 by the Rasmitogen-activated protein kinase pathway
58. Regulation of BAD phosphorylation and association with bcl-x(L) by the MAPK/ERK kinase
59. CREB couples neurotrophin signals to survival messages
60. Is CREB a key to neuronal survival?
61. Activation of the Bcl-2 promoter by nerve growth factor is mediated by the p42/p44 MAPK cascade
62. Epidermal growth factor receptor-dependent control of keratinocyte survival and Bcl-xL expression through a MEK-dependent pathway
63. Hypoxia-induced VEGF enhances tumor survivability via suppression of serum deprivation-induced apoptosis
64. Epidermal growth factor (EGF) suppresses staurosporine-induced apoptosis by inducing Mcl-1 via the mitogen-activated protein kinase pathway
65. MEK/ERK signaling pathway regulates the expression of Bcl-2, Bcl-X(L), and Mcl-1 and promotes survival of human pancreatic cancer cells
66. Mcl-1 is a common target of stem cell factor and interleukin-5 for apoptosis prevention activity via MEK/MAPK and PI-3K/Akt pathways
67. + thymocytes and supports their differentiation to the CD4 lineage
68. The antiapoptotic gene Mcl-1 is up-regulated by the phosphatidylinositol 3-kinase/Akt signaling pathway through a transcription factor complex containing CREB
69. 2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism
70. Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38 and may mediate activation of CREB
71. Cloning and characterization of RLPK, a novel RSK-related protein kinase
72. RSK-B, a novel ribosomal S6 kinase family member, is a CREB kinase under dominant control of p38α mitogen-activated protein kinase (p38αMAPK)
73. The role of 3-phosphoinositide-dependent protein kinase 1 in activating AGC kinases defined in embryonic stem cells
74. Nuclear localization and regulation of ERK- and RSK-encoded protein kinases
75. MSK1 is required for CREB phosphorylation in response to mitogens in mouse embryonic stem cells
76. CREB: A stimulus-induced transcription factor activated by a diverse array of extracellular signals
77. Phosphorylation and inactivation of BAD by mitochondria-anchored protein kinase A
78. Regulation of BAD by cAMP-dependent protein kinase is mediated via phosphorylation of a novel site, Ser155
79. Phosphorylation of the pro-apoptotic protein BAD on serine 155, a novel site, contributes to cell survival
80. 14-3-3 Proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation
81. Growth factors inactivate the cell death promoter BAD by phosphorylation of its BH3 domain on Ser155
82. BAD Set-155 phosphorylation regulates BAD/Bcl-XL interaction and cell survival
83. CREB is a regulatory target for the protein kinase Akt/PKB
84. Akt/protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein
85. Specificity of receptor tyrosine kinase signalling-transient versus sustained extracellular signal-regulated kinase activation
86. Integrating the MAP kinase signal into the G1 phase cell cycle machinery
87. The neuron-glia signal β-neuregulin induces sustained CREB phosphorylation on Ser-133 in cultured rat Schwann cells
88. Growth-factor-dependent mitogenesis requires two distinct phases of signalling
89. Embryonic death of Mek1-deficient mice reveals a role for this kinase in angiogenesis in the labyrinthine region of the placenta
90. Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice
91. Altered extracellular signal-regulated kinase signaling and glycogen metabolism in skeletal muscle from p90 ribosomal S6 kinase 2 knockout mice
92. Mutations in the X-linked RSK2 gene (RPS6KA3) in patients with Coffin-Lowry syndrome
93. Mutations in the kinase Rsk-2 associated with Coffin-Lowry syndrome
94. A novel ribosomal S6-kinase (RSK4; RPS6KA6) is commonly deleted in patients with complex X-linked mental retardation
95. A transcript map of an 800-kb region on human chromosome 11q13, part of the candidate region for SCA5 and BBS1
96. A founder effect in the Newfoundland population reduces the Bardet-Biedl syndrome I (BBS1) interval to 1 cM
97. Eighteen new polymorphic markers in the multiple endocrine neoplasia type 1 (MEN1) region
98. Cooperative transformation of 32D cells by the combined expression of IRS-1 and V-Ha-Ras
99. Synergistic activation of mitogen-activated protein kinase by cyclic AMP and myeloid growth factors opposes cyclic AMP's growth-inhibitory effects
100. Both src-dependent and -independent mechanisms mediate phosphatidylinositol 3-kinase regulation of colony-stimulating factor 1-activated mitogen-activated protein kinases in myeloid progenitors
101. Analysis of antiapoptosis activity of human GM-CSF receptor
102. Two distinct signaling pathways downstream of Janus kinase 2 play redundant roles for anti-apoptotic activity of granulocyte-macrophage colony-stimulating factor
103. Activation of the Ras/mitogen-activated protein kinase pathway by kinase-defective epidermal growth factor receptors results in cell survival but not proliferation
104. Opposing effects of sodium salicylate and haematopoietic cytokines IL-3, IL-5 and GM-CSF on mitogen-activated protein kinases and apoptosis of EoL-1 cells
105. Survival function of ERK1/2 as IL-3-activated, staurosporine-resistant Bd2 kinases
106. Evidence for involvement of mitogen-activated protein kinase, rather than stress-activated protein kinase, in potentiation of 1-β-D-arabinofuranosylcytosine-induced apoptosis by interruption of protein kinase C signaling
107. Inhibition of the MAPK pathway abrogates BCL2-mediated survival of leukemia cells after exposure to low-dose ionizing radiation
108. Cell cycle-dependent activation of mitogen-activated protein kinase kinase (MEK-1/2) in myeloid leukemia cell lines and induction of growth inhibition and apoptosis by inhibitors of RAS signaling
109. Coordinate regulation of stress- and mitogen-activated protein kinases in the apoptotic actions of ceramide and sphingosine
110. 12-O-Tetradecanoyl phorbol 13-acetate, protein kinase C (PKC) activator, protects human leukemia HL-60 cells from Taxol-induced apoptosis: Possible role for extracellular signal-regulated kinase
111. Distinct roles of JNKs/p38 MAP kinase and ERKs in apoptosis and survival of HCD-57 cells induced by withdrawal or addition of erythropoietin
112. Transforming growth factor β1 rescues serum deprivation-induced apoptosis via the mitogen-activated protein kinase (MAPK) pathway in macrophages
113. Role of mitogen-activated protein kinases in S-nitrosoglutathione-induced macrophage apoptosis
114. BDNF protects the neonatal brain from hypoxic-ischemic injury in vivo via the ERK pathway
115. Neurotrophic effect of basic fibroblast growth factor is mediated by the p42/p44 mitogen-activated protein kinase cascade in cultured rat cortical neurons
116. Neuroprotection by brain-derived neurotrophic factor is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase
117. Midkine inhibits caspase-dependent apoptosis via the activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase in cultured neurons
118. 2+ ionophore-induced apoptosis of cultured cortical neurons: Involvement of dual pathways
119. PACAP-38 protects cerebellar granule cells from apoptosis
120. Pituitary adenylate cyclase-activating polypeptide (PACAP-38) protects cerebellar granule neurons from apoptosis by activating the mitogen-activated protein kinase (MAP kinase) pathway
121. The TrkB-Shc site signals neuronal survival and local axon growth via MEK and P13-kinase
122. The Ras/phosphatidylinositol 3-kinase, and Ras/ERK pathways function as independent survival modules each of which inhibits a distinct apoptotic signaling pathway in sympathetic neurons
123. A role for MAPK/ERK in sympathetic neuron survival: Protection against a p53-dependent, JNK-independent induction of apoptosis by 1-β-D-arabinofuranosylcytosine
124. The mitogen-activated protein kinase cascade mediates neurotrophic effect of epidermal growth factor in cultured rat hippocampal neurons
125. Phosphatidylinositol 3-kinase and Akt protein kinase mediate IGF-I- and prosaptide-induced survival in Schwann cells
126. Schwann cell development in embryonic mouse nerves
127. Endogenous and exogenous fibroblast growth factor 2 support survival of chick retinal neurons by control of neuronal bcl-x(L) and bcl-2 expression through a fibroblast growth factor receptor 1- and ERK-dependent pathway
128. Spatial and temporal growth factor influences on developing midbrain dopaminergic neurons
129. Gab1 mediates neurite outgrowth, DNA synthesis, and survival in PC12 cells
130. Prevention of PC12 cell death by N-acetylcysteine requires activation of the Ras pathway
131. Angiotensin type 2 receptor dephosphorylates Bcl-2 by activating mitogen-activated protein kinase phosphatase-1 and induces apoptosis
132. Effects of dopamine and L-DOPA on survival of PC12 cells
133. Growth arrest-specific gene 6 (Gas6)/adhesion related kinase (Ark) signaling promotes gonadotropin-releasing hormone neuronal survival via extracellular signal-regulated kinase (ERK) and Akt
134. Reciprocal role of ERK and NF-κB pathways in survival and activation of osteoclasts
135. Inhibition of mitogen-activated protein kinase kinase induces apoptosis of human chondrocytes
136. Autocrine FGF signaling is required for vascular smooth muscle cell survival in vitro
137. Cardiotrophin 1 (CT-1) inhibition of cardiac myocyte apoptosis via a mitogen-activated protein kinase-dependent pathway. Divergence from downstream CT-1 signals for myocardial cell hypertrophy
138. Endothelin-1 inhibits apoptosis of vascular smooth muscle Cells induced by nitric oxide and serum deprivation via MAP kinase pathway
139. Urocortin protects against ischemic and reperfusion injury via a MAPK-dependent pathway
140. The extracellular signal-regulated kinase pathway contributes to mitogenic and antiapoptotic effects of peroxisome proliferators in vitro
141. The role of protein kinase B and mitogen-activated protein kinase in epidermal growth factor and tumor necrosis factor α-mediated rat hepatocyte survival and apoptosis
142. MAPK activation determines renal epithelial cell survival during oxidative injury
143. VEGF prevents apoptosis of human microvascular endothelial cells via opposing effects on MAPK/ERK and SAPK/JNK signaling
144. SAPK2/p38-dependent F-actin reorganization regulates early membrane blebbing during stress-induced apoptosis
145. Endogenous FGF1-induced activation and synthesis of extracellular signal-regulated kinase 2 reduce cell apoptosis in retinal-pigmented epithelial cells
146. MAP kinase pathway signalling is essential for extracellular matrix determined mammary epithelial cell survival
147. Dendritic cell survival and maturation are regulated by different signaling pathways
148. Ambient temperature regulation of apoptosis in brown adipose tissue. Erk1/2 promotes norepinephrine-dependent cell survival
149. Blockade of the extracellular signal-regulated kinase pathway induces marked G1 cell cycle arrest and apoptosis in tumor cells in which the pathway is constitutively activated: Up-regulation of p27Kip1
150. Two independent signaling pathways mediate the antiapoptotic action of macrophage-stimulating protein on epithelial cells
151. Extracellular-regulated kinase activation and CAS/Crk coupling regulate cell migration and suppress apoptosis during invasion of the extracellular matrix
152. Insulin/IGF-I rescues immortalized brown adipocytes from apoptosis down-regulating Bcl-xS expression, in a PI 3-kinase- and map kinase-dependent manner
153. Dual control of muscle cell survival by distinct growth factor-regulated signaling pathways
154. The phosphatidylinositol 3′-kinase pathway is a dominant growth factor-activated cell survival pathway in LNCaP human prostate carcinoma cells
155. Cisplatin-induced activation of mitogen-activated protein kinases in ovarian carcinoma cells: Inhibition of extracellular signal-regulated kinase activity increases sensitivity to cisplatin
156. Association of apoptosis with the inhibition of extracellular signal- regulated protein kinase activity in the tumor necrosis factor α-resistant ovarian carcinoma cell line UCI 101
157. The cellular response to oxidative stress: Influences of mitogen-activated protein kinase signalling pathways on cell survival
158. The activation of p38 and apoptosis by the inhibition of Erk is antagonized by the phosphoinositide 3-kinase/Akt pathway
159. 2-mediated injury of human endothelial cells
160. Radiation-induced release of transforming growth factor a activates the epidermal growth factor receptor and mitogen-activated protein kinase pathway in carcinoma cells, leading to increased proliferation and protection from radiation-induced cell death
161. 2+-permeable AMPA receptors induce phosphorylation of cAMP response element-binding protein through a phosphatidylinositol 3-kinase-dependent stimulation of the mitogen-activated protein kinase signaling cascade in neurons
162. Mitogen-activated protein kinase (MAPK) activation by butylated hydroxytoluene hydroperoxide: Implications for cellular survival and tumor promotion
163. Fibrinogen interactions with ICAM-1 (CD54) regulate endothelial cell survival
164. Nitric oxide down-regulates MKP-3 mRNA levels: Involvement in endothelial cell protection from apoptosis
165. The p42/p44 MAP kinase pathway prevents apoptosis induced by anchorage and serum removal
166. Anti-apoptotic signaling by hepatocyte growth factor/Met via the phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways
167. i-protein-mediated activation of mitogen-activated protein kinase
168. 2. Role in cell survival following oxidant injury
169. B-Raf inhibits programmed cell death downstream of cytochrome o release from mitochondria by activating the MEK/Erk pathway
170. The role of phosphatidylinositide-3-kinase in basal mitogen-activated protein kinase activity and cell survival